Production (Stage)
Knight Therapeutics Inc.
KHTRF
$4.17
-$0.289-6.48%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 125.83M | 120.12M | 127.55M | 115.05M | 141.84M |
| Total Receivables | 87.33M | 78.91M | 76.24M | 69.34M | 70.56M |
| Inventory | 97.51M | 71.38M | 85.09M | 75.73M | 70.45M |
| Prepaid Expenses | 5.19M | 5.38M | 5.39M | 3.36M | 3.88M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 132.90K |
| Total Current Assets | 315.86M | 275.79M | 294.29M | 263.48M | 286.86M |
|
|
|||||
| Total Current Assets | 315.86M | 275.79M | 294.29M | 263.48M | 286.86M |
| Net Property, Plant & Equipment | 14.59M | 13.92M | 16.02M | 15.70M | 15.91M |
| Long-term Investments | 62.63M | 60.10M | 62.76M | 61.82M | 63.14M |
| Goodwill | 62.63M | 60.10M | 62.76M | 61.82M | 63.14M |
| Total Other Intangibles | 189.97M | 197.11M | 207.03M | 215.94M | 214.70M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 53.91M | 51.05M | 54.02M | 52.74M | 59.01M |
| Total Assets | 697.84M | 669.84M | 712.31M | 690.73M | 715.01M |
|
|
|||||
| Total Accounts Payable | 81.92M | 54.45M | 64.12M | 56.85M | 63.54M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 1.47M | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 16.84M | 12.52M | 16.07M | 14.29M | 16.32M |
| Total Finance Division Other Current Liabilities | 7.41M | 8.88M | 7.27M | 6.18M | 6.17M |
| Total Other Current Liabilities | 7.41M | 8.88M | 7.27M | 6.18M | 6.17M |
| Total Current Liabilities | 106.18M | 77.32M | 87.46M | 77.32M | 86.02M |
|
|
|||||
| Total Current Liabilities | 106.18M | 77.32M | 87.46M | 77.32M | 86.02M |
| Long-Term Debt | 18.32M | 18.00M | 24.40M | 24.82M | 31.70M |
| Short-term Debt | -- | 1.47M | -- | -- | -- |
| Capital Leases | 2.35M | 2.39M | 2.63M | 3.35M | 3.74M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 17.59M | 19.54M | 24.96M | 27.90M | 30.89M |
| Total Liabilities | 144.44M | 117.24M | 139.45M | 133.39M | 152.36M |
|
|
|||||
| Common Stock & APIC | 388.13M | 389.18M | 418.62M | 413.99M | 418.45M |
| Retained Earnings | 109.09M | 107.58M | 106.73M | 105.40M | 108.07M |
| Treasury Stock & Other | 56.18M | 55.83M | 47.52M | 37.95M | 36.12M |
| Total Common Equity | 553.41M | 552.60M | 572.86M | 557.34M | 562.65M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 553.41M | 552.60M | 572.86M | 557.34M | 562.65M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 553.41M | 552.60M | 572.86M | 557.34M | 562.65M |
|
|
|||||